Dolutegravir
Back to search| Scientific Name: | Dolutegravir |
| Brand Name: | Dovato, Juluca, Tivicay, Triumeq |
| Company Owner: | Not Available |
| Mechanism Of Action | Dolutegravir is an HIV-1 antiviral agent. It inhibits HIV integrase by binding to the active site and blocking the strand transfer step of retroviral DNA integration in the host cell. The strand transfer step is essential in the HIV replication cycle and results in the inhibition of viral activity. Dolutegravir has a mean EC50 value of 0.5 nM (0.21 ng/mL) to 2.1 nM (0.85 ng/mL) in peripheral blood mononuclear cells (PBMCs) and MT-4 cells. |
| Description of the Drug: | Dolutegravir is an antiviral agent used for the treatment of HIV-1 infections in combination with other antiretroviral agents. |
| Protein Data Bank: |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB08930
